| [1] |
Glenner GG, Wong CW.Alzheimer′s disease，initial report of the purification and characterization of a novel cerebrovascular amyloid protein[J]．Biochem Biophys Res Commun，1984，120(3):885-889.
|
| [2] |
Goedert M, Wischik CM, Crowther RA，et al.Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease，identification as the microtubule-associated protein tau[J]．Proc Natl Acad Sci USA，1988，85(11):4051-4055.
|
| [3] |
Thornton TM, Pedraza-Alva G, Deng B，et al.Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation[J]．Science，2008，320(5876):667-670.
|
| [4] |
Sharfi H, Eldar-Finkelman H．Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling[J]．Am J Physiol Endocrinol Metab，294(2):E307-E315.
|
| [5] |
O′Brien WT, Haung J, Buccafusca R，et al.Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice[J]．J Clin Invest.2011，121(9):3756-3762.
|
| [6] |
Holsinger RM, McLean CA, Beyreuther K，et al.Increased expression of the amyloid precursor beta-secretase in Alzheimer′s disease[J]．Ann Neurol，2002，51(6):783-786.
|
| [7] |
Cai H, Wang Y, McCarthy D，et al.BACE1 is the major beta-secretase for generation of A beta peptides by neurons[J]．Nat Neurosci，2001，4(3):233-234.
|
| [8] |
Ly PT, Wu Y, Zou H，et al.Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes[J]．J Clin Invest，2013，123(1):224-235.
|
| [9] |
Rezai-Zadeh K, Douglas Shytle R, Bai Y，et al.Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer′s disease beta-amyloid production[J]．J Cell Mol Med，2009，13(3):574-588.
|
| [10] |
Deng Y, Xiong Z, Chen P，et al.β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3[J]．Neurobiol Aging，2014，35(3):449-459.
|
| [11] |
Townsend M, Mehta T, Selkoe DJ.Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway[J]．J Biol Chem，2007，282(46):33305-33312.
|
| [12] |
Magdesian MH, Carvalho MM, Mendes FA，et al.Amyloid-beta binds to the extracellular cysteine-rich domain of frizzled and inhibits Wnt/beta-catenin signaling[J]．J Biol Chem，2008，283(14):9359-9368.
|
| [13] |
Hui J, Zhang J, Pu M, et al. Modulation of GSK-3β/β-Catenin signaling contributes to learning and memory impairment in a rat model of depression[J]．Int J Neuropsychopharmacol，2018，21(9):858-870.
|
| [14] |
Hanger DP, Noble W．Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation[J]．Int J Alzheimers Dis，2011(2011):352805.
|
| [15] |
Saeki K, Machida M, Kinoshita Y，et al.Glycogen synthase kinase-3β2 has lower phosphorylation activity to tau than glycogen synthase kinase-3β1[J]．Biol Pharm Bull，2011，34(1):146-149.
|
| [16] |
Vossel KA, Zhang K, Brodbeck J，et al.Tau reduction prevents Abeta-induced defects in axonal transport[J]．Science，2010，330(6001):198.
|
| [17] |
Vossel KA, Xu JC, Fomenko V，et al.Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β[J]．J Cell Biol，2015，209(3):419-433.
|
| [18] |
Wang H, Wang R, Zhao Z，et al.Coexistences of insulin signaling-related proteins and choline acetyltransferase in neurons[J]．Brain Res，2009(1249):237-243.
|
| [19] |
Wang JZ, Wang ZH.Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration[J]．Exp Gerontol，2015(68):82-86.
|
| [20] |
Del Pino J, Zeballos G, Anadn MJ，et al.Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade，increase in GSK-3β enzyme，β-amyloid and tau protein levels[J]．Arch Toxicol，2016，90(5):1081-1092.
|
| [21] |
Samadi A, Valderas C, de los Ríos C, et al. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases.II.Synthesis，biological assessment，and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles[J]．Bioorg Med Chem，2011，19(1):122-133.
|
| [22] |
Provensi G, Costa A, Passani MB，et al.Donepezil，an acetylcholine esterase inhibitor，and ABT-239，a histamine H3 receptor antagonist/inverse agonist，require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse[J]．Neuropharmacology，2016(109):139-147.
|
| [23] |
Llorens-Martin M, Lpez-Domnech G, Soriano E，et al.GSK3β is involved in the relief of mitochondria pausing in a tau-dependent manner[J]．PLoS One，2011，6(11):e27686.
|
| [24] |
Llorens-Martín M, Fuster-Matanzo A, Teixeira CM，et al.GSK-3β overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo[J]．Mol Psychiatry，2013，18(4):451-460.
|
| [25] |
Buss H, Dörrie A, Schmitz ML，et al.Phosphorylation of serine 468 by GSK3β negatively regulates basal p65 NF-κB activity[J]．J Biol Chem，2004，279(48):49571-49574.
|
| [26] |
Zhang H, Yang X, Qin X，et al.Caspase-3 is involved in aluminum-induced impairment of long-term potentiation in rats through the Akt/GSK-3β pathway[J]．Neurotox Res，2016，29(4):484-494.
|
| [27] |
Egashira Y, Tanaka T, Soni P，et al.Involvement of the p75(NTR) signaling pathway in persistent synaptic suppression coupled with synapse elimination following repeated long-term depression induction[J]．J Neurosci Res，2010，88(16):3433-3446.
|
| [28] |
Olsen KM, Sheng M．NMDA receptors and BAX are essential for Abeta impairment of LTP[J]．Sci Rep，2012(2):225.
|
| [29] |
Martin M, Rehani K, Jope RS，et al.Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3[J]．Nat Immunol，2005，6(8):777-784.
|
| [30] |
Fuster-Matanzo A, Llorens-Martin M, de Barreda EG，et al.Different susceptibility to neurodegeneration of dorsal and ventral hippocampal dentate gyrus：a study with transgenic mice overexpressing GSK3β[J]．PLoS One，2011，6(11):e27262.
|
| [31] |
Ding Y, Qiao A, Fan GH.Indirubin-3-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer′s disease[J]．Neurobiol Dis，2010，39(2):156-168.
|
| [32] |
Avrahami L, Farfara D, Shaham-Kol M，et al.Inhibition of glycogen synthase kinase-3 ameliorates betaamyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model：in vivo and in vitro studies[J]．J Biol Chem，2013，288(2):1295-1306.
|
| [33] |
Gameiro I, Michalska P, Tenti G，et al.Discovery of the first dual GSK3βinhibitor/Nrf2 inducer.a new multitarget therapeutic strategy for Alzheimer′s disease[J]．Sci Rep，2017(7):45701.
|
| [34] |
张军臣，张冉，张广宁，等．槲皮素对颞叶癫痫大鼠学习记忆能力的影响[J/CD]．中华诊断学电子杂志，2016，4(2):131-135.
|
| [35] |
Jiang XY, Chen TK, Zhou JT，et al.Dual GSK-3β/AChE inhibitors as a new strategy for multitargeting anti-alzheimer′s disease drug discovery[J]．ACS Med Chem Lett，2018，9(3):171-176.
|
| [36] |
何昊，关青，张浩波，等．新版轻度认知障碍临床指南概要[J/CD]．中华诊断学电子杂志，2018，6(3):145-150.
|
| [37] |
Toledo EM, Inestrosa NC.Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease[J]．Mol Psychiatry，2010，15(3):228,272-285.
|
| [38] |
Sudduth TL, Wilson JG, Everhart A，et al.Lithium treatment of APPSwDI/NOS2-/-mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype[J]．PLoS ONE，2012(7):e31993.
|
| [39] |
Forlenza OV, Diniz BS, Radanovic M, et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment：randomised controlled trial[J]．Br J Psychiatry，2011，198(5):351-356.
|
| [40] |
Pomara N．Lithium treatment in Alzheimer′s disease does not promote cognitive enhancement，but may exert long-term neuroprotective effects[J]．Psychopharmacology(Berl)，2009，205(1):169-170.
|
| [41] |
Huang HJ, Chen SL, Huang HY，et al.Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice[J]．Psychopharmacology (Berl)，2018.[Epub ahead of print]
|
| [42] |
Rong H, Liang Y, Niu Y．Rosmarinic acid attenuates β-amyloid-induced oxidative stress via Akt/GSK-3β/Fyn-mediated Nrf2 activation in PC12 cells[J]．Free Radic Biol Med，2018(120):114-123.
|
| [43] |
Paudel P, Seong SH, Zhou Y，et al.Rosmarinic acid derivatives′ inhibition of glycogen synthase kinase-3β is the pharmacological basis of kangen-karyu in alzheimer′s disease[J]．Molecules，2018，23(11):E2919.
|